BMS-986205 (Linrodostat) is a selective indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor.
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Molecular Weight | 410.91 |
Formula | C24H24ClFN2O |
CAS Number | 1923833-60-6 |
Purity | 99.56% |
Solubility | DMSO 60 mg/mL |
Storage | at -20°C |
[1] George C Prendergast, et al. Cancer Res. Discovery of IDO1 Inhibitors: From Bench to Bedside
[2] Cancer Discov. Blocking IDO1 Helps Shrink Bladder, Cervical Tumors.
Related IDO Products |
---|
IDO-IN-4
IDO-IN-4 is an indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor, extracted from patent WO2014150677A1, Compound example 1 enantiomer 1. |
(Rac)-Indoximod
(Rac)-Indoximod(1-methyl-DL-tryptophan) is an indoleamine 2, 3-dioxygenase (IDO) inhibitor. |
LY-3381916
LY-3381916 (IDO1-IN-5) is a potent IDO1 inhibitor that can penetrate the blood brain barrier. LY-3381916 May show antitumor activity. |
NLG-919 (Navoximod)
Navoximod (GDC-0919; Nlg-919) is an effective IDO (indoleamine-(2,3)-dioxygenase) inhibitor with Ki/EC50 of 7 nM/75 nM respectively. |
BMS-986242
BMS-986242 is an orally active, potent and selective indoleamine-2,3-dioxygenase 1 (IDO1) inhibitor. BMS-986242 can be used in cancer research. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.